ADVANCED PROTEOME THERAPEUTICS CORPORATION

Advanced Proteome Therapeutics Corporation

Equities

APC.H

CA0076282098

Investment Holding Companies

Delayed Toronto S.E. Other stock markets 03:55:53 2023-12-04 pm EST			5-day change	1st Jan Change
0.005 ^CAD	-.--%		-.--%	-.--%

2023	Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	CI
2023	Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	CI

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Advanced Proteome Therapeutics Corporation

Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-29	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-03-28	CI
Advanced Proteome Therapeutics Corporation agreed to Spin-Off Linceis Capital Corp.	23-01-16	CI
Advanced Proteome Therapeutics Corporation announced that it has received CAD 0.0725 million in funding from Conation Capital	22-12-22	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	22-12-21	CI
Advanced Proteome Therapeutics Corporation Appoints Mr. Cory Brandolini to the Board of Directors	22-11-20	CI
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	22-11-14	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	22-11-14	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	22-06-28	CI
Advanced Proteome Therapeutics up 28.5%, Receives Notice of Allowance for Patent Claims	22-04-13	MT
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	22-03-25	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	21-12-17	CI
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	21-11-28	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	21-11-28	CI
Advanced Proteome Therapeutics Provides Update on COVID Program	21-08-24	MT
Advanced Proteome Therapeutics : Appoints Benjamin Krantz to CEO of US Subsidiary	21-07-21	MT
Advanced Proteome Therapeutics Announces Appointment of Benjamin Krantz to CEO	21-07-21	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021	21-06-29	CI
Advanced Proteome Therapeutics : Announces Senior Appointments	21-06-09	MT
Advanced Proteome Therapeutics Corporation Announces Appointment of New Scientific Advisory Board Member	21-06-09	CI
Advanced Proteome Therapeutics Corporation announced that it has received CAD 1.5 million in funding	21-04-12	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2021	21-03-30	CI
Advanced Proteome Therapeutics : French second-hand car group Aramis eyeing IPO	21-03-08	RE
Advanced Proteome Therapeutics Corporation announced that it expects to receive CAD 1.25 million in funding	21-02-28	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2020	20-12-29	CI

Chart Advanced Proteome Therapeutics Corporation

Duration

Period

Chart Advanced Proteome Therapeutics Corporation

More charts

Company Profile

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.

Sector

Investment Holding Companies

Calendar

2024-06-24 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

	1st Jan change	Capi.
ADVANCED PROTEOME THERAPEUTICS CORPORATION	-.--%	150K
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+119.94%	4.88B
SCREAMING EAGLE ACQUISITION CORP.	+1.60%	1.01B
CHURCHILL CAPITAL CORP VII	+2.29%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+27.64%	836M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+1.80%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+23.11%	578M

Shell Companies